Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Mutations in a P-type ATPase gene cause axonal degeneration.

Zhu X, Libby RT, de Vries WN, Smith RS, Wright DL, Bronson RT, Seburn KL, John SW.

PLoS Genet. 2012;8(8):e1002853. doi: 10.1371/journal.pgen.1002853. Epub 2012 Aug 9.

2.

The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.

Mi W, Beirowski B, Gillingwater TH, Adalbert R, Wagner D, Grumme D, Osaka H, Conforti L, Arnhold S, Addicks K, Wada K, Ribchester RR, Coleman MP.

Brain. 2005 Feb;128(Pt 2):405-16. Epub 2005 Jan 11.

PMID:
15644421
3.

Axonal Degeneration in Retinal Ganglion Cells Is Associated with a Membrane Polarity-Sensitive Redox Process.

Almasieh M, Catrinescu MM, Binan L, Costantino S, Levin LA.

J Neurosci. 2017 Apr 5;37(14):3824-3839. doi: 10.1523/JNEUROSCI.3882-16.2017. Epub 2017 Mar 8.

4.

Progressive white matter pathology in the spinal cord of transgenic mice expressing mutant (P301L) human tau.

Lin WL, Zehr C, Lewis J, Hutton M, Yen SH, Dickson DW.

J Neurocytol. 2005 Dec;34(6):397-410. Epub 2006 Aug 10.

PMID:
16902761
5.

C-terminus of the P4-ATPase ATP8A2 functions in protein folding and regulation of phospholipid flippase activity.

Chalat M, Moleschi K, Molday RS.

Mol Biol Cell. 2017 Feb 1;28(3):452-462. doi: 10.1091/mbc.E16-06-0453. Epub 2016 Dec 8.

6.

WldS can delay Wallerian degeneration in mice when interaction with valosin-containing protein is weakened.

Beirowski B, Morreale G, Conforti L, Mazzola F, Di Stefano M, Wilbrey A, Babetto E, Janeckova L, Magni G, Coleman MP.

Neuroscience. 2010 Mar 10;166(1):201-11. doi: 10.1016/j.neuroscience.2009.12.024. Epub 2009 Dec 16.

PMID:
20018231
7.

Localization, purification, and functional reconstitution of the P4-ATPase Atp8a2, a phosphatidylserine flippase in photoreceptor disc membranes.

Coleman JA, Kwok MC, Molday RS.

J Biol Chem. 2009 Nov 20;284(47):32670-9. doi: 10.1074/jbc.M109.047415. Epub 2009 Sep 24.

8.

Transport through recycling endosomes requires EHD1 recruitment by a phosphatidylserine translocase.

Lee S, Uchida Y, Wang J, Matsudaira T, Nakagawa T, Kishimoto T, Mukai K, Inaba T, Kobayashi T, Molday RS, Taguchi T, Arai H.

EMBO J. 2015 Mar 4;34(5):669-88. doi: 10.15252/embj.201489703. Epub 2015 Jan 16.

9.

Wallerian degeneration in the optic nerve of the wabbler-lethal (wl/wl) mouse.

Carroll EW, Curtis RL, Sullivan DA, Melvin JL.

Brain Res Bull. 1992 Sep-Oct;29(3-4):411-8.

PMID:
1382814
10.
11.

Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport.

Ferreirinha F, Quattrini A, Pirozzi M, Valsecchi V, Dina G, Broccoli V, Auricchio A, Piemonte F, Tozzi G, Gaeta L, Casari G, Ballabio A, Rugarli EI.

J Clin Invest. 2004 Jan;113(2):231-42.

12.

The gene for slow Wallerian degeneration (Wld(s)) is also protective against vincristine neuropathy.

Wang M, Wu Y, Culver DG, Glass JD.

Neurobiol Dis. 2001 Feb;8(1):155-61.

PMID:
11162249
13.

Mechanisms of axonal spheroid formation in central nervous system Wallerian degeneration.

Beirowski B, Nógrádi A, Babetto E, Garcia-Alias G, Coleman MP.

J Neuropathol Exp Neurol. 2010 May;69(5):455-72. doi: 10.1097/NEN.0b013e3181da84db.

PMID:
20418780
14.

Phospholipid flippase ATP8A2 is required for normal visual and auditory function and photoreceptor and spiral ganglion cell survival.

Coleman JA, Zhu X, Djajadi HR, Molday LL, Smith RS, Libby RT, John SW, Molday RS.

J Cell Sci. 2014 Mar 1;127(Pt 5):1138-49. doi: 10.1242/jcs.145052. Epub 2014 Jan 10.

15.

Degeneration of neuronal cell bodies following axonal injury in Wld(S) mice.

Wang AL, Yuan M, Neufeld AH.

J Neurosci Res. 2006 Dec;84(8):1799-807.

PMID:
17022038
16.

Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.

Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM.

Neuron. 2002 May 16;34(4):521-33.

17.

Disruption of the ATP8A2 gene in a patient with a t(10;13) de novo balanced translocation and a severe neurological phenotype.

Cacciagli P, Haddad MR, Mignon-Ravix C, El-Waly B, Moncla A, Missirian C, Chabrol B, Villard L.

Eur J Hum Genet. 2010 Dec;18(12):1360-3. doi: 10.1038/ejhg.2010.126. Epub 2010 Aug 4.

18.

Sprouting of axonal collaterals after spinal cord injury is prevented by delayed axonal degeneration.

Collyer E, Catenaccio A, Lemaitre D, Diaz P, Valenzuela V, Bronfman F, Court FA.

Exp Neurol. 2014 Nov;261:451-61. doi: 10.1016/j.expneurol.2014.07.014. Epub 2014 Jul 28.

PMID:
25079366
19.

Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system.

Coleman MP, Ribchester RR.

Curr Drug Targets CNS Neurol Disord. 2004 Jun;3(3):227-38. Review.

PMID:
15180483
20.

Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein.

Spittaels K, Van den Haute C, Van Dorpe J, Bruynseels K, Vandezande K, Laenen I, Geerts H, Mercken M, Sciot R, Van Lommel A, Loos R, Van Leuven F.

Am J Pathol. 1999 Dec;155(6):2153-65.

Supplemental Content

Support Center